nephrotic syndrome is a heterogeneous entity. Patients who respond to therapy (completely or partially) have Background. Pure diffuse mesangial hypercellularity (DMH ), in its primary form, is a relatively rare a benign course similar to that of minimal change nephrotic syndrome. They are usually older and have histological finding and few data exist in the literature regarding its clinical course and prognosis in nephrotic normal renal function at presentation, whereas 'sclerotic' lesions are less frequent findings in initial biopsies. adults with this diagnosis. Methods. We retrospectively analysed the clinical and Non-responders tend to be younger and progress to ESRD. Most of them have impaired renal function at histological data of 28 adult nephrotic patients (13 male) with this diagnosis with regard to response to first assessment and more prominent 'sclerotic' lesions on initial biopsies. Mesangial IgM is an independent the treatment, outcome and prognostic indicators. Results. Of 25 patients treated with prednisolone marker of poorer response to treatment and progression to ESRD but it lacks specificity. (Pred ), nine (36%) showed complete remission (CR) of proteinuria, eight (32%) partial remission (PR) and Keywords: diffuse mesangial hypercellularity; IgM eight (32%) did not respond at all (NR). The combinanephropathy; nephrotic syndrome; treatment; outtion of cyclosporin treatment with prednisolone of come; prognosis those with PR or NR produced one further complete and two partial remissions. At the end of follow-up (mean 64 months), 10 patients (40%) were in CR, nine (36%) in PR and six (24%) were NR and remained Introduction nephrotic. Renal function remained unchanged in patients with CR or PR. In contrast, the six nonDiffuse mesangial hypercellularity (DMH ) in idioresponders progressed to end-stage renal disease pathic nephrotic syndrome (NS ) was described origin-( ESRD 
(36%) in PR and six (24%) were NR and remained Introduction nephrotic. Renal function remained unchanged in patients with CR or PR. In contrast, the six nonDiffuse mesangial hypercellularity (DMH ) in idioresponders progressed to end-stage renal disease pathic nephrotic syndrome (NS ) was described origin-( ESRD). Compared with non-responders, patients ally by Churg et al. [1] and White et al. [2] in 1970. who responded to Pred were older and had normal This histopathological pattern is relatively uncommon renal function at presentation. This group also had in Europe and North America where it is thought to less mesangial sclerosis and severe tubulointerstitial account for 2-10% of all patients with NS [1, 3, 4] . fibrosis and none showed synechiae with Bowman's DMH has been described in some patients with mincapsule. IgM mesangial deposits were observed in 22% imal change nephrotic syndrome (MCNS ) who freof patients with CR in response to Pred, in 37% of quently are steroid resistant or steroid dependent [5] [6] [7] . those with PR and in 100% of non-responders, who DMH in idiopathic NS has also been seen in associfinally progressed to ESRD. A multivariate analysis of ation with focal segmental glomerulosclerosis (FSGS ) clinical and histological features at biopsy showed or the deposition of mesangial IgM [8, 9] . The relationpersistent nephrotic syndrome (P<0.001), the severity ship between DMH, MCNS and FSGS remains of DMH (P<0.03) and the presence of mesangial IgM unclear. Some authors suggested that DMH (with or (P<0.01) to have independent predictive value for without IgM deposits) is a distinct entity [10] , while ESRD. This analysis also demonstrated that only others classified the lesion with MCNS [11, 12] . Others, mesangial sclerosis (P<0.03) and the presence of meshowever, believe that these three entities represent a angial IgM (P<0.002) independently predicted the continuum and that, over time, DMH may convert to response to therapy.
normal, MCNS or FSGS [7] . Conclusions. DMH associated with idiopathic Also, studies on the significance of mesangial IgM deposits fall into two groups, those that favour the Correspondence and offprint requests to: E. Alexopoulos, MD, distinction of an IgM mesangial nephropathy as a inflammatory tubulointerstitial ( TIN ) infiltrate and the presthat come to the conclusion that the presence of IgM ence of arteriosclerosis were also evaluated and graded on a is not of major significance [8, [19] [20] [21] [22] .
scale from 0 to 3.
The relative paucity of information on the clinical course and pathological findings of adult patients with Definitions this rare condition prompted us to analyse retrospectively our data on 28 adult patients with idiopathic NS NS was defined as proteinuria of >3 g/24 h together with a in whom the diagnosis of DMH was made. An attempt serum albumin of <3 g/dl. Haematuria was defined as >5 was also made to identify prognostic indicators of red blood cells per high power field. Normal renal function outcome or response to therapy of this lesion and its was defined as a plasma creatinine of ∏1.3 mg/dl. Renal possible relationship to MCNS and FSGS.
insufficiency was defined as a persistent rise in plasma creatinine >1.3 mg/dl, and end-stage renal disease ( ESRD) was the point at which dialysis treatment was started or Subjects and methods plasma creatinine exceeded 10 mg/dl.
Patients with a diastolic blood pressure of >90 mmHg or From 1984 to 1996, clinical and histological data of all adult a systolic pressure >140 mmHg were considered hypertenspatients (>15 years of age) with NS and renal biopsies ive. The outcome was defined as follows: complete remission showing DMH were reviewed. The diagnosis of idiopathic was defined as when there was a stable reduction in urinary DMH was based on the following criteria [23, 24] : (i) the protein excretion to ∏0.25 g/24 h, and partial remission as presence of three or more cells per mesangial region in a when proteinuria ranged between 0.26 and <3 g/24 h in the thin, 2-3 mm section away from the vascular pole; (ii) a presence of stable renal function. lesion involving >80% of the glomeruli in the specimen; (iii) the absence of double contours or spikes of the glomerTreatment ular capillary walls visible by silver impregnation; (iv) the absence of dense deposits in the basement membranes visible Twenty-five treated patients initially received prednisolone with the trichrome stain; and (v) no clinical or histological at a dose of 1 mg/kg/day for >1 month with progressive evidence of associated disease such as IgA nephropathy, tapering. The average duration of treatment was 6 months Henoch-Schö nlein purpura, systemic lupus erythematosus, (range 4-8 months). In patients with partial or no response vasculitis, HIV or streptococcal infection, or hepatic disease.
to prednisolone, cyclosporin (CyA) or cyclophosphamide in All biopsies included in this study contained >10 glomeruli combination with low dose oral prednisolone were given. per biopsy (median 18 glomeruli per biopsy, range CyA was given at a daily dose of 2-3 mg/kg (target wholein order to exclude the possibility of missing FSGS due to blood levels 200-300 ng/ml ) for an average period of 9 sampling error [9] . The diagnosis of FSGS required the months (range 8-12 months) and cyclophosphamide at a presence of scarring in a portion of some but not all daily dose of 1-2 mg/kg for 2 months. glomeruli. Even the presence of a single glomerulus with segmental hyalinosis or scar of the glomerular tuft was sufficient to diagnose FSGS [9] . Patients showing classic Statistical analysis FSGS in addition to DMH at the time of first diagnosis were also excluded from this analysis. Grading of the cellular-Comparisons of clinical or histological data were performed ity was done on the basis of the number of mesangial cells using student's t-test for paired and unpaired data as well as per peripheral mesangial area according to criteria adopted x2 statistics. Multivariate analysis was used to detect indeby the WHO Committee on Classification and Nomenclature pendent effects on outcome of each clinical or histological of Renal Diseases [23] . One or two mesangial cells per area parameter assessed. A similar approach was used to evaluate were accepted as normal, whereas three cells were indicative the impact of these same features on the response to therapy. of mild mesangial hypercellularity, 4-5 cells represented A P-value of <0.05 was considered significant. moderate hypercellularity, and >5 cells were graded as severe hypercellularity. Based on these criteria, a total of 28 patients were identified. Clinical and laboratory information Results for each patient was available both at the time of biopsy and throughout their follow-up.
A review of 751 renal biopsies performed between 1984 All biopsies were taken using a standard Trucut needle, and 1996 revealed 28 patients (3.7%) with idiopathic before instituting treatment. In each case, four stains were DMH associated with NS. Clinical and demographic available for review by light microscopy: haematoxylin data of the patients are presented in Table 1 . All and eosin, Masson trichrome, periodic acid-Schiff and patients had NS at biopsy and 19 (68%) had microsilver methenamine period acid-Schiff (Jones). Immunofluorescence studies were done using labelled antisera against scopic haematuria. Nine patients (32%) had a plasma IgG, IgA, IgM, C3, C4 and fibrinogen. Lesions with sole or creatinine >1.5 mg/dl at presentation. Hypertension dominant IgM deposits in the mesangium were categorized was found in 12 patients (43%). The mean period of in the IgM-positive group. Optical microscopy findings were follow-up was 64 months (range 8-156 months).
analysed and classified by two independent observers (E.A.
Histological data of the patients are presented in and A.P.) without knowledge of patient identity or outcome. Table 2 . DMH was found in all patients affecting most In addition to establishing the diagnosis, the following fea-of the glomeruli (>80%) and, in each glomerulus, all tures were recorded: the presence of mesangial sclerosis; the mesangial areas were similarly affected ( Figure 1) . presence of epithelial cell proliferation; the presence of syneEighteen patients (64%) showed mesangial sclerosis chiae with Bowman's capsule; and the presence of diffuse usually of mild severity. Focal glomerular epithelial mesangial deposits of IgM and C3. Furthermore, the severity of tubular atrophy and interstitial fibrosis, the extent of cell hyperplasia was observed in four patients (15%) prednisolone, had two relapses of NS which always Fig. 1 . Light photomicrography of a glomerulus with mesangial widening and severe diffuse mesangial hypercellularity (PAS×400). plete or partial response to the treatment ( Table 3) . In contrast, all six non-responsive patients reached ESRD aPatients with complete and partial response were included. during the period of observation. Three CyA-treated bValues are means±standard deviation. patients developed hypertrichosis and one gum hyper-GEC=glomerular epithelial cell; TIN=tubulointerstitial. plasia. Both complications reverted after CyA treatment was completed. In addition, mild hypertension contrast, the severity of proteinuria was similar in occurred in two patients, which was treated with a both groups. calcium blocker. Mesangial sclerosis was a universal finding in nonresponsive patients (100%) but it was found less freClinicopathological correlations and prognostic quently in the group of responders (58%, P<0.005) indicators ( Table 4 ). In addition, synechiae with Bowman's capsule were not seen in any biopsy of the responders, Based on a multivariate analysis of clinical characterwhereas they were observed in all biopsies of nonistics, only the severity of proteinuria was found to be responsive patients (100%). Also, significant tubulopredictive of the degree of renal function impairment interstitial fibrosis (Á2+) was seen more rarely in at the time of biopsy (P<0.01). When patients entering responders (23%) than in non-responders (50%, remission were excluded from the analysis, only pro-P<0.03). Clinical characteristics of patients with or teinuria (P<0.001) was a significant independent risk without mesangial IgM deposits are summarized in factor for outcome ( ESRD). None of the other clinical Table 5 . No significant differences between the two parameters including age and sex were predictive of groups were observed. However, the presence of mesrenal survival. When this analysis was performed evaluangial IgM was associated with a poorer response to ating histological features only, the severity of mesangtherapy ( Table 6 ). With regard to the initial response ial hypercellularity (P<0.03) and the presence of diffuse mesangial IgM (P<0.01) had independent pre- to prednisolone, IgM deposition was seen in 22% of (ISKDC ) [5] . Considering our patients as a single patients with a complete response, in 37% of those group, the response to steroids is comparable with the with a partial response and in all patients (100%) who 64% response rate reported by us in patients with did not respond at all (Figure 2 ). When the data were 'classic' FSGS and NS, after prolonged treatment analysed according to the final response to the treat-(average 9 months) with prednisolone [28] . On this ment, IgM deposits were present in 20% of patients basis, DMH in adults with NS must be clearly differenwith a complete response, in 55% of those with a tiated from MCNS and should be regarded as a distinct partial response and in 100% of patients who failed to entity. A closer look, however, reveals heterogeneous respond to any form of therapy. population with regard to response to steroids. Almost The multivariate analysis demonstrated that no clin-one-third of the patients respond completely to predniical feature at the time of biopsy was predictive of a solone in a way similar to that of patients with MCNS, response to treatment. Of the histological findings that and some have a relapsing course. Of the remaining, we measured at the time of biopsy, only the presence almost one-third remain steroid resistant throughout of mesangial sclerosis (P<0.03) and the presence of their course, and the remaining one-third show an mesangial IgM (P<0.002) independently predicted the intermediate response with persisting non-nephrotic response to therapy.
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proteinuria. The use of cytotoxic drugs in the treatment of steroid-resistant cases is of little benefit. No response Discussion to cyclophosphamide therapy was observed in four patients with initial resistance to steroids. In agreement The results of the present study showed that adult with the results of the SPNSG [27] and the ISKDG patients with DMH and NS respond less well to [5], our findings suggest that treatment with cytotoxic prednisolone when compared with those with MCNS. drugs is probably unwarranted in patients with DMH Large clinical studies on adult patients with MCNS who are unresponsive to steroids. CyA has been used showed that corticosteroids induce a remission of NS in a few patients with DMH and steroid-resistant NS, in 81-95% of all patients [25, 26 ] . Contrary to these, but, at present, no conclusion can be drawn regarding only 68% of our patients with DMH responded to its efficacy because only a small number of patients prednisolone with complete or partial remission of have been treated so far [29] [30] [31] . Of the eight patients proteinuria. The poorer response obtained in this study who initially were resistant to prednisolone (including is similar to that reported in children in the Southwest four patients non-responsive to cyclophosphamide), Pediatric Nephrology Study Group (SPNSG) [27] and two (25%) went into complete remission after prothe International Study of Kidney Disease in Children longed treatment with CyA. Of those with an initial partial response, CyA induced complete remission in one patient and sustained a partial response in the remaining seven. Overall, at the latest follow-up, 40% of our patients were in complete remission, 36% in partial remission while 24% did not respond to any form of treatment and remained nephrotic. We suggest, therefore, that CyA at a low dose for a prolonged period of time is safe and may be considered as an alternative treatment for patients with partial or no response to steroids. The long-term prognosis of patients with DMH and NS is not as good as in those with MCNS, and ESRD occurs exceptionally in the latter group [25, 26, 32] . However, the response to the treatment is the most important clinical factor that determines the final outcome. Renal function remained stable in all patients ment. In contrast, all six non-responsive patients (24%) E. Alexopoulos et al. 986 had a protracted course and developed progressive loss progressed to terminal renal failure. The multivariate analysis also demonstrated that the presence of mesof renal function culminating in ESRD. This is also true for children, where the reported incidence of angial IgM had an independent predictive value for response to therapy. These results indicate that the azotaemia or ESRD among non-responders varies from 21 to 40% in different reports [7, 12] . The above presence of mesangial IgM deposits in association with DMH increases the likelihood of resistance to therapy findings are supported further by the multivariate analysis which demonstrated that persistent NS was and reflects a more severe course of clinical disease.
However, it lacks specificity since almost one-third of the only significant independent predictor of renal survival.
the responders showed similar deposits, but the absence of IgM deposition is always associated with a favourFrom this analysis, it was found that no clinical feature that we measured at the time of biopsy was able response to treatment and excellent long-term outcome. Thus, despite different opinions [8, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , predictive of response to treatment. However, a simple comparison between responders and non-responders our results support the view that DMH with IgM mesangial deposits is not a distinct clinicopathological showed that steroid-responsive patients were older and had normal renal function at biopsy. In contrast, non-entity, and the presence of mesangial IgM deposition correlates frequently, but not always, with a poorer responders were much younger and most of them had impaired renal function at first assessment. Otherwise, response to treatment and worse outcome.
At present, we can conclude that adult patients with both groups did not differ with regard to the severity of DMH, the prevalence of haematuria or the degree DMH and NS represent a heterogeneous group with different clinical courses despite similar morphological of proteinuria. The reason why younger adult patients with this lesion are more often resistant to steroids is appearance in initial biopsies [33] . A considerable number of patients are responsive to therapy and do not clear. Waldherr and co-workers [7] reported an even lower rate of complete (12%) or partial (19%) not progress to chronic renal failure. This group has many similarities with those with MCNS. Another responsiveness to steroids in nephrotic children with similar histological appearance. Perhaps different group of patients is not responsive to therapy and progresses to ESRD. This group always shows IgM pathogenetic mechanisms may operate at different stages of life in producing the same lesion, some of mesangial deposition and may represent an intermediate stage of transition to true FSGS. With the which are steroid sensitive.
When a multivariate analysis was carried out to group of partial responders, it is difficult to come to any definite conclusion. These patients show an exceldetermine if any of the histological parameters had an influence on the response to treatment, only the pres-lent clinical outcome but a poorer response to treatment. Whether they will lose their subnephrotic ence of mesangial sclerosis had an independent predictive value. Mesangial sclerosis and significant TIN proteinuria spontaneously [7] or progress to frank FSGS at a later stage of their course is uncertain. fibrosis were identified more frequently in nonresponders. Also, synechiae with Bowman's capsule Perhaps, serial biopsies taken at regular intervals in this group coupled with a longer follow-up can provide were seen in all biopsies of non-responsive patients and in none of the responders. Subsequent renal biop-an answer to this question. sies in two non-responders taken within 1 and 4 years after the initial diagnosis showed FSGS. Do these
